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Abstract
More than 95% of the human population is infected with human herpesvirus-6 (HHV-6) during early childhood and
maintains latent HHV-6 genomes either in an extra-chromosomal form or as a chromosomally integrated HHV-6 (ciHHV-6).
In addition, approximately 1% of humans are born with an inheritable form of ciHHV-6 integrated into the telomeres of
chromosomes. Immunosuppression and stress conditions can reactivate latent HHV-6 replication, which is associated with
clinical complications and even death. We have previously shown that Chlamydia trachomatis infection reactivates ciHHV-6
and induces the formation of extra-chromosomal viral DNA in ciHHV-6 cells. Here, we propose a model and provide
experimental evidence for the mechanism of ciHHV-6 reactivation. Infection with Chlamydia induced a transient shortening
of telomeric ends, which subsequently led to increased telomeric circle (t-circle) formation and incomplete reconstitution of
circular viral genomes containing single viral direct repeat (DR). Correspondingly, short t-circles containing parts of the HHV-
6 DR were detected in cells from individuals with genetically inherited ciHHV-6. Furthermore, telomere shortening induced
in the absence of Chlamydia infection also caused circularization of ciHHV-6, supporting a t-circle based mechanism for
ciHHV-6 reactivation.
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Introduction
Human herpesvirus 6 (HHV-6) is a ubiquitous pathogen with
.90% seroprevalence in healthy adults. Although the process of
viral latency is not completely understood, in some cases it is
achieved by the integration of the viral genome into telomeric
regions of host cell chromosomes (ciHHV-6) [1], and then
subsequently vertically transmitted through the germ line [1–3].
Approximately 1% of the human population carries genetically
inherited HHV-6. After becoming latent, HHV-6 persists in a
dormant state with minimal viral transcription or translation in
human host cells and without the production of infectious virions
and any detectable clinical complications. However, under various
physiological conditions, latent HHV-6 is reactivated and forms
infectious viral particles (for further details see reviews [4–6]).
Reactivated HHV-6 has been associated with various human
diseases [7–10].
The ,160 kb linear double-stranded genome of both species of
HHV-6 (HHV-6A and -6B) is flanked by two distinct regions,
ranging from 8 to 13 kb in length [11–13], called direct repeats
(DR) at the left (DRL) and the right (DRR) ends of the genome,
respectively. Multiple passages of HHV-6 in the laboratory have
led to the shortening of DR due to the deletion of specific regions
in DRL and DRR [11,12]. Both the DR regions possess two well-
defined stretches of telomeric repeats (T1 and T2). These repeat
regions contain several copies of the sequence (TTAGGG)n, which
are also found at the termini of linear eukaryotic chromosomes.
The left end of each DR has short heterogeneous stretches of
telomeric repeats (DRL-T1 and DRR-T1) whereas the right end of
both the DRs has a single long stretch of homogeneous telomeric
repeats (DRL-T2 and DRR-T2). Several other herpesviruses
including Marek’s disease virus (MDV) and HHV-7 have a
similar genome organization containing multiple stretches of
telomeric repeats at both ends. Although chromosomal integration
of HHV-7 has not been identified so far, it has been suggested that
homologous recombination between viral telomeric repeats and
human telomeres mediates the integration of HHV-6 [14] and
MDV [15] into the host cell genome. The presence of telomeric
repeats within the viral genome may have dual functions, required
for both the integration (to acquire latency) and its excision
(to reactivate from latency) [14,16]. However, the reactivation
machinery and the exact mechanism for HHV-6 reactivation are
currently unknown.
We have previously shown that replication of the ciHHV-6
genome is efficiently reactivated in blood cells of patients that
are infected with C. trachomatis without the formation of viral
particles [17]. In this study, we have used Chlamydia infection as
a model to understand the mechanism of ciHHV-6 reactivation.
Our results provide strong evidence for the existence of a t-circle
based mechanism for the circularization of the integrated viral
genome, which is possibly independent of the viral infectious
cycle.
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Results
A model for ciHHV-6 reactivation
The reproducible and strong reactivation of ciHHV-6 replica-
tion by Chlamydia suggests that chlamydial infection triggers the
exit of the integrated virus from the host genome and the
subsequent formation of circular viral DNA, which functions as
a template for rolling circle replication. Since previous work
has demonstrated that HHV-6 contains telomere-like sequences
within its genome and it integrates within the telomeres of euka-
ryotic chromosomes we investigated the role of these sequences
in ciHHV-6 reactivation. We devised a hypothesis for the reac-
tivation mechanism based on the following considerations: (1)
since telomeres are dynamic DNA structures, they are subject to
reorganization by the telomere maintenance machinery [18].
Therefore, the HHV-6 reactivation may be a consequence of
the direct changes of telomeres at chromosomal ends. (2) The
reactivated HHV-6 must form a circular DNA to allow rolling
circle replication. (3) The circular HHV-6 DNA must maintain at
least one complete and reconstituted DR with the packaging signal
sequences pac1 and pac2. These sequences are required for the
packaging and assembly of intact viral particles. (4) If the telomeric
repeats mediate viral reactivation, excised extra-chromosomal
HHV-6 should have variable telomeric-sequence lengths. Based
on these considerations, we propose the model presented in
Figure 1 as a basic mechanism for the formation of complete and
reconstituted viral DNA.
HHV-6 integrates into telomeric regions of human chromo-
somes possibly by homologous recombination [2,14] and in
the process loses the distal end of the viral genome including the
DRR- pac2 signal sequence essential for the packaging of viral
DNA [2,16] (Step 1; Figure 1). During the cell cycle, telomeric
repeats can be added to the end of chromosomes by the cellular
telomerase complex containing the RNA subunit hTR and
the catalytic subunit, hTERT. We therefore propose that the
overhanging end (step 1, DRL; Figure 1) of ciHHV-6 will
progressively shorten during subsequent cell divisions until
the host telomerase complex is able to bind to the exposed
heterogeneous viral telomeric repeats and add telomeric repeats to
stabilize the chromosomal ends. This process should lead to the
loss of the pac1 sequence from the DRL of the integrated viral
genome (Figure 1). We hypothesize two ways by which the viral
genome can subsequently be excised from the chromosome: (i)
by homologous recombination within the integrated viral genome
leading to circular viral DNA formation possibly mediated by the
telomeric circle (t-circle) formation machinery of the host cell or (ii)
by telomeric loop (t-loop) formation by branch migration and
Holliday junction resolution (See reviews [18–20]). T -circles
are duplex or single-stranded extra-chromosomal DNA circles
formed from telomeric repeat sequences at the ends of human
chromosomes and play a key role in maintenance of telomeres
[20] whereas t-loops are loop like structures, frequently found at
telomeric ends of chromosomes, which stabilize the telomere
through the formation of the multiprotein shelterin complex [18].
T-loop formation is frequently observed in many different cell
types; whereas single homologous recombination events during
alternate lengthening of telomeres is suggested to form circular
DNA molecules (t-circles) in the absence of telomerase activity
[21,22]. Since the extra-chromosomal HHV-6 DNA must be in a
circular form for rolling circular replication, we considered both
the t-circle and/or t-loop formation as possible mechanisms by
which ciHHV-6 can form extra-chromosomal circular viral DNA.
There are two major possibilities for the successful reconstitu-
tion of the circular viral genome. A homologous recombination
event between DRL-T1 and DRR-T1 would lead to the formation
of a circular viral genome with a fixed length of DR-T2 and the
presence of an incomplete DRL in the human genome of
reactivated cells. Alternatively, the left end of the DRL could be
first removed by a shorter t-circle formation process (Step 2,
Figure 1), resulting in telomeric elongation of the chromosomal
end from a homogenous telomeric repeat region of DRL (DRL-T2)
(Step 3, Figure 1). A second t-circle formation between DRL-T2
(Step 4, Figure 1) and DRR-T2 would result in the excision of the
whole viral genome from the chromosome thereby generating a
circular viral genome with a single reconstituted DR (Step 4,
Figure 1). The circular viral genome can further undergo rolling
circle amplification to form concatemeric viral DNA that can be
cleaved to form linear double-stranded viral DNA molecules
including two complete DRL and DRR sequences (Step 5,
Figure 1).
Chlamydia infection induces transient telomere
shortening
Reactivation of ciHHV-6 from human telomeres may be
initiated by structural changes at the chromosomal ends. To
analyze whether chlamydial infection has any impact on
chromosomal ends, changes in telomere length were measured
by telomere restriction fragment analysis during C. trachomatis
infection. This assay determines telomere lengths by digesting
DNA with frequently cutting restriction enzymes that do not
cleave within telomeric sequences. Interestingly, we observed
strong telomere shortening between 24–36 h of Chlamydia infection
in different cell types including wild type HeLa (Figure 2A),
HeLa229 (Figure S1A) and one of the ciHHV-6A cell lines (HSB-
ML) (Figures 2B), which was followed by partial repair of telomeric
ends. The presence of any nonspecific DNA degradation during
Chlamydia infection was excluded by control hybridizations (Figure
S1A). Termination of chlamydial infection by the addition of
doxycycline, 24 h post infection, prevented telomere shortening
indicating an active involvement of Chlamydia in this process
(Figures 2B, S1A). Interestingly, persistent Chlamydia, a viable
but non-productive form of Chlamydia induced by addition of
Author Summary
Human herpesviruses (HHVs) can reside in a lifelong non-
infectious state displaying limited activity in their host and
protected from immune responses. One possible way by
which HHV-6 achieves this state is by integrating into the
telomeric ends of human chromosomes, which are highly
repetitive sequences that protect the ends of chromo-
somes from damage. Various stress conditions can
reactivate latent HHV-6 thus increasing the severity of
multiple human disorders. Recently, we have identified
Chlamydia infection as a natural cause of latent HHV-6
reactivation. Here, we have sought to elucidate the
molecular mechanism of HHV-6 reactivation. HHV-6 effi-
ciently utilizes the well-organized telomere maintenance
machinery of the host cell to exit from its inactive state and
initiate replication to form new viral DNA. We provide
experimental evidence that the shortening of telomeres, as
a consequence of interference with telomere maintenance,
triggers the release of the integrated virus from the
chromosome. Our data provide a mechanistic basis to
understand HHV-6 reactivation scenarios, which in light of
the high prevalence of HHV-6 infection and the possibility
of chromosomal integration of other common viruses like
HHV-7 have important medical consequences for several
million people worldwide.
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Figure 1. Proposed model for the reactivation of ciHHV-6. ciHHV-6 DNA has to be processed two times in order to form a t-circle containing a
single DR, which can then undergo rolling circle amplification to form linear HHV-6 DNA. DR, direct repeats; DRL, left direct repeat; DRR, right direct
repeat; T1, heterogeneous telomeric repeats; T2, homogeneous telomeric repeats; pac1 and pac2, packaging sequence 1 and 2; OriLyt, origin of lytic
replication.
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penicillin, inhibited telomere repair (Figure 2C), suggesting that
both telomere shortening and repair are actively induced by
Chlamydia infection. The loss of telomeric sequences and subse-
quent defective telomere repair were also detected by fluorescent
in situ hybridization (FISH) 48 h after Chlamydia infection
(Figure 2D), where several single chromatids in Chlamydia infected
cells showed weak or no telomeric signal (Figure 2D).
To test if HHV-6 reactivation involves t-circle formation after
Chlamydia infection, we applied neutral-neutral 2D DNA electro-
phoresis. This method enables the discrimination between linear
and circular DNA of the same size (Figure S1B) due to their
differential migration in agarose gels [23]. This unusual migration
behavior of DNA can be further resolved by either increasing the
voltage or agarose concentration. Based on this principle, DNA is
Figure 2. C. trachomatis (Ctr) infection induces telomere alterations. (A) HeLa (wild type) (B) HSB-ML cells were infected with C. trachomatis
for different time intervals. Mock-infected or 1 mg/ml doxycycline (Dox)-treated cells were used as control. Total genomic DNA (10 mg) was digested
with MspI and HhaI and telomeric sequences were detected by Southern hybridization using an end-labeled (CCCTAA)4 probe (Tel-C probe). The
positions of molecular weight markers are shown on the left. Dox was added to cells wherever mentioned (+Dox) after 24 h post Ctr infection and the
cells were grown for further time intervals. Mock, cells with no Chlamydia infection. (C) Penicillin (Pen)-induced Chlamydia persistence prevents
telomere repairing. Where indicated, 100 U of penicillin was added 24 h post Chlamydia infection. (D) FISH analysis of metaphase chromosomes
showing telomere shortening in HeLa cells infected with Chlamydia. Telomeres were hybridized with a Cy5-tagged telomeric C-rich (Tel-C) probe and
are shown in the red channel; DNA was stained with 49,6-diamidino-2-phenylindole (DAPI) and is shown in the blue channel. Arrows indicate missing
telomeric staining from single sister chromatids. Representative individual chromosomes are enlarged to show telomere staining. (E) Detection of
circular telomeric DNA in PBMCs after Chlamydia infection. Freshly isolated PBMCs from healthy individuals were either mock infected or with Ctr for
2 days. Subsequently, cells were cultured for 2 more weeks in presence of doxycycline. Genomic DNA from each sample was digested with HinfI and
RsaI and was processed for 2D-DNA electrophoresis and subsequent Southern hybridization with Tel-C probe. Black arrowhead indicates circular
telomeric DNA. hpi, hour post infection; dpi, days post infection; wpi, week post infection.
doi:10.1371/journal.pgen.1004033.g002
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separated in two different dimensions during 2D DNA electro-
phoresis, first according to mass and then according to shape.
The method has been previously extensively used to study the
organization of telomeric DNA [23–28]. Interestingly, we detected
increased t-circle formation in primary human PBMCs (Figure 2E)
as well as in HeLa cells (Figure S1C) after Chlamydia infection.
Thus, our data provide strong evidence for changes in telomere
length and increased t-circle formation during Chlamydia infection,
which can contribute to ciHHV-6 excision from human telomeres
and subsequent reactivation.
Reactivated HHV-6 genomes contain telomeric repeats of
different length and exist in different conformations
The presence of well-defined stretches of telomeric repeats
within the viral DR could potentially lead to the formation of t-
circles of variable sizes thereby generating viral DNA containing
telomeric repeats of differing lengths. To investigate the excision
of viral genomes as a consequence of t-circle formation, we
investigated two different viral reactivation scenarios. We have
frequently observed viral integration into host cell chromosomes
during productive infection of HSB-2 cells. These cells produc-
tively infected with HHV-6A (Figure S2A) contained a fraction of
the replicating viruses integrating into the telomeres (Figure S2B)
and therefore could serve as source for virus replication and
reactivation. Alternatively, we selected HSB-ML cells, which in
contrast harbor ciHHV-6A and undergo viral reactivation and
formation of extra-chromosomal viral DNA upon infection with
Chlamydia (see Materials and Methods for details). To compare the
length of tandem arrays of telomeric repeats, extra-chromosomal
viral DNA was isolated from these cells using low melting DNA gel
electrophoresis and then subjected to telomere restriction fragment
analysis. In addition, S1 nuclease digests were used to monitor the
amount of single-stranded nucleic acids in the isolated DNA.
Differential lengths of telomeric repeats ranging from 0.25 to 2 kb
in length were detected during productive HHV-6 infection
in HSB-2 cells and in HSB-ML cells after virus reactivation
(Figure 3A).
To check for the presence of multiple conformations of extra-
chromosomal viral genomes, 2D DNA electrophoresis was
performed with total DNA from HHV-6A-infected HSB-2 cells
and ciHHV-6 HSB-ML cells reactivated by chlamydial infection.
We detected circular HHV-6 DNA (marked with a white
arrowhead in Figure 3B) in addition to the linear viral genome
(marked with a red arrowhead) in HSB-2 cells, which co-
hybridized with two different telomeric probes as well as with
the HHV-6 specific probe (Figure 3B). However, HSB-ML cells
contained very low amounts of circular DNA upon reactivation
by Chlamydia infection. In addition, we observed a distinct band
of viral DNA that was smaller in size in both samples from the
different cell-lines (Figure 3B, blue arrow head), which may
represent a shorter form of circular viral DNA. Full-length circular
as well as linear double-stranded HHV-6 DNA was also detected
in the total DNA isolated from primary PBMCs from one ciHHV-
6 patient (Figure 3C) with ongoing natural viral reactivation at
the time of blood sample collection. During further analysis,
single-stranded circular HHV-6 DNA was detected in Chlamydia
reactivated HSB-ML cells (marked with yellow arrowhead in
Figure S2C), whereas this form was hardly detectable in HHV-6A
infected HSB-2 cells (Figure S2C). Single-stranded circular viral
DNA was clearly longer in size than the average telomeric circle in
eukaryotic cells (Figure S2C) and was not present in control DNA
samples (Figure S2D). S1 nuclease treatment digested both forms
of circular DNA (Figure S2E) thereby confirming the presence of
nicked circular double-stranded and/or single-stranded circular
viral DNA in HHV-6A-infected cells.
To verify the presence of short t-circles in ciHHV-6A harboring
HSB-ML cells, we gel purified DNA bands of approximately
10 kb in size (verified for presence of HHV-6 by southern
hybridization) and performed TEM analysis. We observed mostly
circular DNAs of varying sizes (Figure 3D) whereas control DNA
preparations from uninfected HSB-2 cells (HHV-6A negative) did
not contain any circular DNA. Thus, these results support our
hypothesis that short t-circles carrying viral DR are formed in
ciHHV-6 cells.
Shortened telomeric ends at DRL-T2 of ciHHV-6 are
generated by frequent t-circle formation
The absence of homogeneous stretches of telomeric repeats at
DRL-T1 suggested that telomere addition and chromosomal end
maintenance might begin from the DRL-T2 region. Therefore, we
expected the formation of shorter t-circles between telomeric
repeats added to DRL-T1 and DRL-T2 (Step 2, Figure 1). This
process should generate a shorter DRL without most of the
DRL ORFs. To test this hypothesis, we performed Southern
hybridization analysis with total DNA from HSB-2 cells with both,
chromosomally integrated HHV-6 and ongoing productive viral
infection (Figures S2A, S2B) and from uninfected HSB-2 cells
(Figure S3A). Re-hybridization of the same blot with 2 different
HHV-6 probes complementary to the two ends of the DRL as well
as with a telomere specific probe confirmed the formation of short
t-circles in these cells. DNA bands of the same length, detected by
2 different HHV-6 probes, could also originate from head-to-tail
fused DNA concatemers. However, the length of head-to-tail
fused concatemers should differ from those originating only from
short t-circle formation (described in detail in Figures S3B, S3C),
supporting the hypothesis that frequent t-circle formation removes
parts of the viral DRL leading to the generation of short circular
DNA molecules containing viral DR.
T-circle formation between DRL-T1 and DRL-T2 (Step 2,
Figure 1) should result in chromosomal ends having overhanging
DRL-T2 (Step 3, Figure 1). To test this, we performed Southern
hybridization analysis with total DNA from HHV-6 infected and
uninfected HSB-2 cells and detected an approximately 950 bp
fragment in infected HSB-2 cells with a probe hybridizing outside
of the DRL that was not detected by a DR-specific probe
(Figures 4A, 4B). Interestingly, this band gave a poor telomeric
hybridization signal, indicating the presence of an extremely short
telomere at its left end. Similar restriction digestion and Southern
hybridization experiment was carried out using total DNA from a
haploid chronic myeloid cell line (KBM-7) [29], infected with
HHV-6A, which allows productive virus infection (Figure S4A).
Viral DNA ending at DRL-T2 as well as different sizes of short
t-circles were detected in these cells (Figure 4C). Thus, the data
suggest that part of the integrated HHV-6 DNA lacks DRL-T1
and contains a very short telomeric overhang starting at DRL-T2.
We detected distinct bands of short circular viral DNAs in HSB-
2 cells with productive viral infection and in the Chlamydia infected
HSB-ML cells (Figure 3B, marked with blue arrowhead). These
short circular DNAs did not hybridize with a probe located in the
U1 region, outside the viral DR, demonstrating that these short t-
circles do not contain viral DNA outside the DR. The size of these
bands correlate with the shorter DNA fragments from gel purified
extra-chromosomal DNA (Figure 3A, marked with red arrowhead)
indicating that short circular DNA molecules containing HHV-6
DR (Step 2, Figure 1) are frequently present in these cells and can
be detected by various methods. Since ciHHV-6 blood DNA
samples cannot be assessed for the presence of short t-circles by
HHV-6 Reactivation by T-Circle Formation
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Southern analysis due to an insufficient DNA yield, we used
inverse PCR to test for the presence of short t-circles in total
DNA from freshly isolated ciHHV-6 PBMCs as well as some of
the previously described cell lines carrying ciHHV-6 (detailed
experimental approach is described in Figure S4). We amplified
fragments of different sizes (Figures 4C), which were subsequently
confirmed by southern hybridization using multiple probes and
in part by sequencing to distinguish between short DRL-T1 and
DRL-T2 containing t-circles (see Text S1). Variable lengths of
telomeric repeats were detected in all the sequenced products,
which did not show any major sequence differences within the
viral DR. Our data indicate that shorter t-circle formation from
ciHHV-6 DRL is a frequent event since several different sizes of
short circular DNA containing partial DRL and its telomeric
repeats were detected in all the cell types tested. Minor differences
in the length of short t-circles were observed in the total DNA
isolated before and after Chlamydia-mediated ciHHV-6 reactiva-
tion in HSB-ML cells and in one sample from ciHHV-6 PBMCs
(P4) (Figure 4D). We detected several smaller amplification
products using the HHV-6 probe 1 (Figure 4D), which was not
detected by telomere probes. This results from the generation of
incomplete PCR products due to difficulties in amplification of
DNA from within highly GC-rich telomeric repeat regions. Thus,
these results confirm our hypothesis that short extra-chromosomal
t-circle formation is a frequent event and it is not altered by the
subsequent reactivation of the viral DNA.
Reactivated circular HHV-6 DNA contains a single DR
Validation of the final steps of the proposed model for HHV-6
reactivation required the detection of circular viral DNA with a
single reconstituted DR (Step 4, Figure 1). We used inverse PCR
with an inverse primer pair (table S1) located outside the DR
(Figure 5A) to amplify circular viral DNA from several different
cell types (Figures 5A, B). Once again, variable lengths of telomeric
repeats were observed in extra-chromosomal HHV-6 DNA
from HSB-2 cells (Figure 3A). Therefore, we size fractionated
the full-length HHV-6A DNA from HSB-2 cells and used it
separately for inverse PCR and subsequent Southern hybridization
to determine the sequence composition of the different PCR
fragments. We amplified circular HHV-6 DNA from HSB-2 cells
as well as from one of the ciHHV-6 PBMCs (P4) infected with C.
trachomatis (Figure 5B). In addition, PCR amplified DNA bands
were gel purified, cloned and sequenced. Sequencing of PCR
products confirmed the results of Southern analysis. The results
clearly differentiated three distinct groups of DRs within these
samples. We identified a fully reconstituted DR ,9.7 kb in one
fraction of total DNA from HSB-2 cells. Two other fractions
contained a ,8 kb smaller DR and one distinct fragment of
,3.2 kb was detected in all the fractions of viral DNA from
HSB-2 cells as well as in the total genomic DNA isolated after
Chlamydia mediated reactivation of ciHHV-6 PBMC (P4). Inter-
estingly, these fragments represented reconstituted short DRs,
which lacked most of the DR (DR1–DR7) (Figure S5A). We also
observed smaller incomplete DRs in HSB-2 cells that were not
detected with probes located between DRL-T1 and DRL-T2 or the
telomeric probe (Figures S5B, S5C, S6) indicating recombination
between DRL-T2 and DRR-T1 facilitated by short telomeric
repeats. Sequencing reads of variable sizes of HHV-6 DNA
containing a single DR confirmed two possible combinations for
t-circle formation, either between DRL-T2 and DRR-T1 or
between DRL-T2 and DRR-T2 resulting in reconstituted DRs. We
observed strong variation in the size of the reconstituted DR-T1
(Figure S6). Interestingly, circular HHV-6 DNA with incomplete
DR were observed in ciHHV-6 PBMC (P4) only after Chlamydia
infection, thereby confirming the viral DNA circularization
event during chlamydial reactivation of ciHHV-6. Even though
circular DNA was present in Chlamydia reactivated HSB-ML cells
(Figure 3C), we could not detect any circular viral DNA by inverse
PCR in these cells. This may be due to sequence variations in the
primer-binding region or formation of a longer DR, which cannot
be amplified in these PCR conditions.
Homologous recombination mediated telomere
shortening is sufficient for the formation of extra-
chromosomal circular HHV-6 molecules
Mammalian telomeric TTAGGG repeats bind the key dimeric
DNA binding protein telomere repeat binding factor-2 (TRF2),
which plays a key role in maintaining telomere integrity [30]. A
mutant of TRF2 with a deletion in the N-terminal basic domain
(TRF2DB) has previously been shown to induce homologous
recombination mediated t-loop formation and subsequent telo-
mere loss [25]. To find experimental evidence for t-circle
dependent ciHHV-6 reactivation, we over-expressed human
TRF2DB (Figure 6A) in various cell types. As expected, TRF2DB
over-expression induced telomere shortening in all the ciHHV-6
cell types tested (Figure 6B) and caused cell death within 5–7
days after lentivirus infection. Since TRF2DB is known to induce
t-circle formation, we predicted that circularization of ciHHV-
6 would be observed in these cells leading to circular extra-
chromosomal viral DNA formation. Extra-chromosomal circular
viral DNA with a single DR was detected by inverse PCR
(as described in Figure 5) and confirmed by Southern analysis
using a HHV-6 specific probe (Figure 6C). Control cells that
did not undergo t-circle formation did not contain circular viral
DNA molecules. In addition, fragments were purified, cloned and
sequenced to verify the origin of the DNA. Thus, our results
confirmed the involvement of the host cell t-circle formation
machinery in ciHHV-6 reactivation.
Figure 3. Extra-chromosomal HHV-6 DNA exists in different conformations and contains telomeric repeats of different sizes. (A)
Purified viral DNA was either digested with MspI and HhaI or with S1 nuclease. All DNA samples were subjected to Southern hybridization using end-
labeled (CCCTAA)4 probe (Tel-C probe), (TTAGGG)4 probe (Tel-G probe) or a HHV-6 DR specific probe (HHV-6 probe 2). HSB-ML+Ctr, Chlamydia-
infected HSB-ML cells; HR ladder, high-range DNA ladder. The position of molecular weight markers is shown on the left. Smaller viral DNAs (possible
short t-circles) are marked with red arrowhead. Possible concatemeric viral DNA are indicated. (B) Total genomic DNA from each cell type was
processed for 2D-DNA electrophoresis and subsequent Southern hybridization with telomere-specific probes as well as with HHV-6 probes 2 and 3.
Colored arrowheads mark different forms of viral DNA. White arrowheads: double-stranded circular HHV-6 DNA; Red arrowheads: double-stranded
linear DNA; Blue arrowheads: short t-circles containing HHV-6 DR; Yellow arrowheads: single-stranded viral DNA (G-strand). DRL: left direct repeat. The
positions of the size markers for the first-dimension gel electrophoresis are shown at the top, the origin of the second-dimension gel electrophoresis
is indicated (Ori). (C) Detection of double-stranded full length circular HHV-6 DNA in PBMCs of ciHHV-6 patients with natural viral reactivation and
with in vitro HHV-6 reactivation. Total genomic DNA from each cell type was processed for neutral-neutral 2D-DNA electrophoresis and subsequent
Southern hybridization with HHV-6 probe 2. White arrowheads indicate double-stranded circular HHV-6 DNA. (D) Defined DNA fragments of ,10 kb
were gel eluted and prepared for EM by surface spreading. Shown is a reverse contrast image. Arrows mark circular t-circles of different sizes.
doi:10.1371/journal.pgen.1004033.g003
HHV-6 Reactivation by T-Circle Formation
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Figure 4. Detection of differentially processed ciHHV-6 ends. (A) Diagram of possible processing of the ciHHV-6 DRL-T2 end after viral
integration. Approximate location of MboI digestion sites within and around viral DR are marked with dotted lines. The location of probes used to
detect specific regions of viral DNA and their expected sizes are indicated. Different positions marked are based on HHV-6A U1102 genome
(X83413.1). (B) Total genomic DNA from HSB-2 cells, with or without HHV-6A infection, were digested with MboI and processed for Southern
hybridization. The membrane was stripped and re-probed sequentially with HHV-6 probe 2, Tel-G probe, HHV-6 probe 3 and finally with HHV-6 probe
1 (See table S1). (C) Similar experiment was performed in KBM-7 cells using HHV-6A probe 5, 6 and Tel-G probe. Chromosomal ends having DRL-T2
overhang is marked with red arrowhead. Short t-circles, which can be detected using Tel-G probe and HHV-6A probe 5 but not with HHV-6A probe 6
are marked with blue arrowhead. The positions of molecular weight markers are shown on the left. (D) Inverse PCR using forward and reverse primer
directed out of the DRL (see Figure S4B for orientation). Equal amount of the PCR products were subjected to Southern hybridization using probes
against telomeric repeats (Tel-G probe). The membrane was rehybridized with a second probe against viral DR (HHV-6 probe 1). P1–P5 represents 5
different DNA samples from ciHHV-6 individuals. P4+Ctr represents PBMCs from P4 after 2 weeks of Chlamydia infection. The positions of molecular
weight markers are shown on the left. The bands, which hybridize with both the probes, represent the extra-chromosomal short t-circles (blue arrow
head). The band marked with red arrowhead represents short t-circles with extremely short telomeric repeats, which do not hybridize with telomeric
probe.
doi:10.1371/journal.pgen.1004033.g004
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Figure 5. PCR amplification of circular HHV-6 genomes having a single direct repeat (DR). (A) Location of primers and southern
hybridization probes to detect each possible combination of circular viral DNA (see table S1). Different positions marked are based on the HHV-6A
U1102 genome (X83413.1). (B) Total DNA was used for PCR using a primer pair facing against each other but located outside the viral DR (see table
S1). PCR products were used for Southern hybridization using HHV-6 probe 2. The membrane was re-hybridized with HHV-6 probe 4 and later on with
telomere (Tel-G) probe. P1–P5 represents 5 different DNA samples from ciHHV-6 individuals. P4+Ctr represents PBMCs from P4 after 2 weeks of
Chlamydia infection. The position of molecular weight markers run is shown on the left.
doi:10.1371/journal.pgen.1004033.g005
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Discussion
Although reactivation of latent HHV-6 has implications in the
progression of many diseases including MS and CFS [8,10,31], the
exact mechanism for latent HHV-6 reactivation, including that
of ciHHV-6, remains unknown. We recently described Chlamydia
infection as a natural trigger to excise the ciHHV-6 genome from
the host cell telomere. In this study, we have followed an ex-
perimental approach to understand the mechanism of ciHHV-6
reactivation.
We found chromosomal integration of HHV-6A in HSB-2 cells
during productive viral infection (Figure S2B). Furthermore, we
have previously reported the presence of ciHHV-6 in HeLa cells
after HHV-6A infection [32] and other human cell lines have been
generated carrying ciHHV-6 [2,16]. Bearing in mind that about
1% of humans carry genetically inherited HHV-6, we propose that
the integration of the HHV-6 genome into human chromosomes
is a frequent event. Reactivation of these integrated HHV-6
sequences likely involves their excision from human chromosomes
leading to the formation of extra-chromosomal HHV-6 genomes
and subsequent replication. HHV-6 contains a potential origin of
lytic replication site (OriLyt) within its linear viral genome [33].
However, a linear genome cannot function as a template for viral
replication. Therefore, circularization of the genome is required
for its continued replication. Although some evidence exists for
head-to-tail fusion and circularization of HHV-6 during viral
DNA replication [13,34], this cannot explain the reactivation
mechanism of ciHHV-6. For example, head-to-tail end fused
viral DNA would maintain the same viral genome size during
productive infection with identical lengths of telomeric repeats
Figure 6. TRF2DB overexpression induces formation of circular HHV-6 genome in ciHHV-6 cells. (A) TRF2 and TRF2DB was over-
expressed in an EBV immortalized cell line (PL-LCL) derived from blood cells of a ciHHV-6 person and in freshly isolated PBMCs of another ciHHV-6
person using lentiviral vectors. Protein expression was checked after 3 days of lentivirus infection by Western blot analysis. GAPDH served as loading
control. *, Uncharacterized protein. (B) Telomere restriction fragment assay was performed in the same cells after 5 days of lentiviral infection using
telomere specific probe. (C) Formation of circular extra-chromosomal HHV-6 DNA was detected in the same cells by inverse PCR. Data represents the
PCR amplifications from PL-LCL cells. As a control PL-LCL cells were infected with C. trachomatis or heat inactivated Ctr (hCtr). Amplified PCR product,
which was validated by sequencing, is marked with a black arrowhead.
doi:10.1371/journal.pgen.1004033.g006
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(DR-T2) within the viral genome. However, we observed viral
DNA with varying lengths of telomeric repeats during viral repli-
cation (Figures 3A, S5, S6) corroborating similar results published
from other laboratories [16,35,36]. As previously demonstrated
[16,37], we detected viral DNA with a single reconstituted DR
(Figure 5), a DNA configuration that cannot originate from end
fusion. Therefore, recombination events involving telomeric
repeats within viral genomes are likely necessary for viral DNA
circularization and subsequent replication. As HHV-6 integrates
within the telomeric repeats located at the ends of human
chromosomes, telomeric recombination events may facilitate the
excision and circularization of integrated HHV-6.
Since C. trachomatis infection reactivates ciHHV-6 replication
[17], we investigated the effect of chlamydial infection on host cell
telomere integrity. Cells infected with C. trachomatis experienced
drastic telomere shortening (Figures 2A, 2B, S1A) and subsequent
repair, which was dependent on the presence of viable and active
bacteria, leading to increased t-circle formation. Changes in
telomere length are frequently correlated with increased t-circle
formation [25,26,38], supporting the hypothesis that Chlamydia-
mediated telomere alteration initiates circularization of ciHHV-6.
In line with this notion, single-stranded viral DNA was detected in
Chlamydia-infected ciHHV-6 cells (Figure S2C) which is also
consistent with the model since telomeric circle formation
frequently leads to formation of single-stranded circular telomeric
DNA [24]. In addition, we recapitulated ciHHV-6 circularization
and viral genome reconstitution by t-circle formation and telomere
shortening independent of Chlamydia infection by modulating
telomeric protein complexes (Figure 6C). Telomeres are regulated
and maintained by the multiprotein shelterin complex, which
includes TRF2 [18]. TRF2 plays a crucial role in preventing non-
homologous end joining at the end of functional telomeres through
the formation of t-loops, thereby protecting telomeres from
potentially harmful deletions [18]. However, the deletion of the
N-terminal basic domain of TRF2 (TRF2DB) enhances t-loop
formation through t-loop homologous recombination [25]. We
utilized these properties of TRF2DB to induce t-loop formation in
ciHHV-6 cells and showed that enhanced t-loop formation led to
weak but definite circularization of viral DNA (Figure 6C). Our
results thus provide direct evidence for the involvement of the
telomere maintenance machinery in viral reactivation.
It is a well-known phenomenon that HHV-6A and -6B produce
high amounts of viral DNA during productive infection but the
formation of infectious viral particles is inefficient [39]. We
propose that the reactivation of ciHHV-6 from human telomeres
is an incomplete process because of the high frequency of shorter
t-circle formation that only rarely results in the successful
reconstitution of a complete viral genome. Frequent loss of viral
DNA between DR1–DR6 in laboratory strains of HHV-6 and
packaging of incomplete HHV-6 DNA lacking parts of DR (DR1–
DR6) has been previously reported [39]. We have also detected
loss of either most of the DR (from DR1–DR8) or parts of the DR
(between DR1–DR7) in various cell types during ciHHV-6
reactivation (Figures S5, S6). On the basis of these results, we
propose that the infectious nature of HHV-6 genome may be
independent of the completeness of the reconstituted circular viral
genome corroborating with earlier reports showing the presence of
incomplete DR in infectious viral particles [39]. Previous
observations of the loss of identical lengths of DR from both ends
of HHV-6 DNA [39] supports our model of HHV-6 replication
from a circular DNA intermediate containing a single DR. Our
results indicate a predominant role of DRL-T2 during viral
circularization (Figures S5, S6). This reinforces the idea that most
of the left part of the viral DRL between pac2 and DRL-T2 is
preferentially removed from the integrated viral genome thereby
producing overhanging viral DNA ends at DRL-T2 (Step 3,
Figure 1), which can subsequently recombine with the telomeric
repeats of DRR (both DRR-T1 or DRR-T2) to form a
reconstituted circular viral genome. The observation of DRL-T2
overhangs at the end of chromosome with frequent short telomeric
repeats (Figures 4B, 4C) is in line with this hypothesis. Recent
studies have utilized single telomere length analysis (STELA)
assays to show similar short, unstable telomeric repeats at the sites
of HHV-6 integration [16,40]. However, results obtained with
STELA assays should be interpreted with caution since extra-
chromosomal telomeric circle-encoded linear DNA containing
parts of the viral DR may also be amplified by this technique. To
our knowledge, this is the first report to show how the telomere
maintenance machinery is exploited to reactivate a latent virus
after a prolonged non-infectious state. The enormous prevalence
of HHV-6 infection and the possibility of chromosomal integration
of other common viruses such as HHV-7, suggests that our data
can form a basis to understand HHV-6 reactivation and the
subsequent medical consequences for several million people
worldwide.
Materials and Methods
Blood cells, cell lines, patients and samples
For the study of latent ciHHV-6 activation, established ciHHV-
6 cell line, HSB-ML (a tetraploid T-cell line derived from HSB-2
cells with 2–5 copies of ciHHV-6), JL-LCL and PL-LCL were
kindly provided by the HHV-6 Foundation, USA (www.hhv-
6foundation.org/, www.bioworldantibodies.com). Haploid chron-
ic myeloid cell line KBM-7 [29] was a kind gift from Prof. Thijn R.
Brummelkamp. Fresh blood samples from 5 individuals with
ciHHV-6 were provided by the HHV-6 Foundation, USA. Viral
load was re-verified by qPCR, which confirmed the ciHHV-6
status of these cells. Wild type HeLa (ATCC CCL-2), HeLa229
(ATCC CCL-2.1) and HSB-2 [32] were grown in RPMI 1640
media and 5% fetal bovine serum (FBS) at 37uC and 5% CO2.
Fresh PBMCs were isolated as described previously [17].
Ethics statement
The ciHHV-6 blood samples were collected under written
informed consent under IRB# CI001-HHV-6 approved by The
Essex Institutional Review Board Committee, USA.
Chlamydia trachomatis infection
Cells were infected with C. trachomatis at a multiplicity of
infection (MOI) of 1–5 as described previously [32].
DNA extraction
Total DNA was extracted from whole blood samples using
QIAamp DNA Blood Mini Kit (Qiagen, Germany) following the
manufacturer’s protocol. DNA extraction from all the cultured
cells was done using DNAzol (Invitrogen) following manufacturer’s
protocol. In particular, all the experiments involving HHV-6 DNA
analysis were carried out using DNA samples extracted with
DNAzol as this method is non-invasive and maintain the genomic
DNA in a non-shearing form.
Activation of HHV-6
To study HHV-6 reactivation, ciHHV-6 cell lines and fresh
blood samples from individuals with ciHHV-6, were infected with
C. trachomatis serovar L2 at an MOI of 1–5. Chlamydial infection
was monitored by phase contrast microscopy. After 2–3 days of
infection, cells were grown in fresh media supplemented with
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1 mg/ml of doxycycline, which allowed Chlamydia-infected cells to
recover.
Telomere restriction fragment (TRF) assay
For telomere length analysis, total DNA from HeLa229 cells
was digested with MspI and HhaI, which do not cut telomeric
DNA, for overnight and then separated on a 0.8% agarose gel.
These gels were subsequently used for Southern hybridization. As
a control, the same DNA samples were digested with HindIII and
processed similarly.
Southern hybridization
For Southern hybridization, agarose gels were incubated in
0.125M HCl for 8–10 min and then in DNA denaturation buffer
(1.5M NaCl, 0.5M NaOH) for 30 min. DNA was transferred to
Nylon-XL membrane (Amersham Hybond-XL, GE life sciences)
by capillary transfer using denaturation buffer for transfer. After
transfer, membrane was washed with neutralization buffer
(3M NaCl, 0.3M Tri-sodium citrate, 0.5M Tris, pH 8.0) for
15 min and was subsequently pre-incubated in hybridization
buffer (GE life sciences, USA). After 1 h of pre-incubation, either
random primed probes (GE life sciences, USA) or end labeled
probes (Table S1) were added to the hybridization buffer and
incubated overnight at 42uC. Membranes were washed and
exposed overnight to phosphor storage screens (Fujifilm), which
were then scanned by Typhoon 9200 imager (GE Healthcare).
PCR amplified Ctr LcrH/SycD gene product of 136 bp was used
for random priming and subsequent as probe. For HHV-6A probe
5 and 6 (Figure 4C), PCR products were amplified using primer
pairs described in Table S1 and were used for random priming.
Neutral–neutral 2D DNA electrophoresis
Separation of DNA in neutral–neutral 2D gels was performed as
previously described [24]. Briefly, 8–10 mg of DNA was digested
with appropriate enzymes and was first separated on 0.4% agarose
at low voltage in 0.56TBE, and the gel was stained with 0.3 mg/
ml ethidium bromide. The lane was cut and placed on a clean gel
support at 90u to the direction of the first electrophoresis, cast with
1.1% agarose containing 0.3 mg/ml ethidium bromide and run in
0.56 TBE. The first dimension was run overnight at 1 V/cm,
and the second at 4 V/cm for 4 h, both at room temperature.
Southern blot analyses were performed as described above.
Extra-chromosomal HHV-6 DNA purification
Total DNA containing HHV-6 DNA was separated using
a 0.6% low melting agarose gel for overnight. After ethidium
bromide staining, the desired bands were cut out and eluted using
the phenol-chloroform extraction method.
Spreading of double-stranded DNA for TEM
Viral DNA was purified from low melting agarose gel.
Prolonged exposure to UV light was prevented in order to avoid
any DNA break. For visualizing double-stranded DNA, purified
DNA in TE-buffer was mixed with ammonium acetate and
cytochrome c (50–200 ng DNA in 2–10 ml TE-buffer, 200 ml 0.2
M ammonium acetate, 0.8–2.0 ml of 1% cytochrome c [in distilled
water]) and 100 ml drops were placed on parafilm. After incu-
bation for 20 min at room temperature, the cytochrome c coated
DNA was picked up by touching collodion-coated grids to the
surface of the drops. Grids were immediately stained with 561025
M uranyl acetate in 90% ethanol or 30 sec, washed for 30 sec in
90% ethanol, air dried and metal coated with platinum/palladium
by rotary shadowing under an angle of 5–7%.
Inverse PCR to detect short t-circles
100 ng of total genomic DNA was used to amplify short t-circles
using a primer pair facing against each other (see table S1)
and Phusion high-fidelity master mix with GC buffer (Thermo
scientific). The following amplification cycles were used: Initial
denaturation at 98uC for 2 minutes, 28 cycles of denaturation at
98uC for 30 seconds, primer annealing at 64uC for 30 seconds and
primer extension at 72uC for 7 minutes. Final extension was done
at 72uC for 30 minutes. Amplified PCR products were run on 1%
agarose gel and were used for Southern hybridization. Amplified
PCR products were cloned into TOPO 2.1 vector and sequenced
using M13 forward and reverse primers.
Inverse PCR for the detection of circular HHV-6 genome
with single DR
100 ng of total genomic DNA was used to amplify circular or
concatemeric HHV-6 DNA having a single direct repeat (DR)
using a primer pair facing against each other (see table S1) and LA
Taq (Takara Biosciences). Long PCR amplification was performed
as follows: an initial cycle of denaturation at 92uC for 4 minutes
was followed by 10 cycles of denaturation at 92uC for 10 seconds,
primer annealing at 64uC for 30 seconds and primer extension at
68uC for 6 min, followed by 20 additional cycles under similar
conditions except that the primer extension time was increased
for 20 seconds per subsequent cycle. PCR was terminated with a
final extension step for 30 minutes at 72uC. Amplified PCR
products were run on 1% agarose gels and subjected to Southern
hybridization. Amplified PCR products were cloned into TOPO
2.1 vector and sequenced using M13 forward and reverse primers.
For inverse PCR in Figure 6C, a different primer pair (For3 and
Rev3, see Table S1) was used.
FISH
FISH and Co-FISH experiments were performed using the
following protocol. Metaphase spreads were prepared after 2–
3 hrs of colcemid treatment using standard cell biology techniques.
For co-FISH, slides were hybridized with 2 different probes using
previously described techniques [41]. For co-FISH with blood
cells, PBMCs were stimulated for 72 h with 10 mg/mL PHA and
then cultured in RPMI1640 media containing 100 units/mL IL-2
and 10% FCS. A custom designed Alexa-488 tagged PNA oligo
probe (Panagene, South Korea) against HHV-6 (Alexa488-
OO-GCG TCA TAA TGC TCA ACA-CONH2) was used for
FISH analysis using manufacturer’s protocol. Alexa488-tagged
Tel-G probes and Cy5-tagged Tel-C probe were purchased from
Eurogentec, Germany (Cat No. PN-TC055-005, TG055-005).
For single chromatid telomere staining (Figure 2D), HeLa cells
were incubated with 5-bromo-29-deoxyuridine (BrdU) and 5-
bromo-29-deoxycytidine (BrdC). Newly synthesized DNA strands
were subsequently digested with Exonuclease III.
Sequence analysis of extra-chromosomal HHV-6 DNA
To validate the origin of extra-chromosomal HHV-6 DNA
from the ciHHV-6, we separated extra-chromosomal HHV-6
DNA from the chromosomal DNA by agarose gel electropho-
resis. DNA from both the fractions were eluted and used for
amplification of viral U94 ORF by PCR. Amplified DNA was
cloned into TOPO 2.1 vector and sequenced.
Lentivirus preparation and overexpression of TRF2DB
Constructs for TRF2 and TRF2DB overexpression [25] were
obtained from Addgene, USA. Detailed protocol for lentivirus
generation and infection are previous described [42]. Rabbit
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monoclonal TRF2 antibody was purchased from Abcam, UK
(Cat no. ab108997).
Supporting Information
Figure S1 Alteration of telomere length during Chlamydia
infection. (A) Chlamydia trachomatis (Ctr) infection induces telomere
shortening without causing genomic DNA degradation. HeLa229
cells were infected with C. trachomatis for different time intervals.
To one of the samples, doxycycline (1 mg/ml) (Dox) was added
after 24 h of Chlamydia infection and allowed to grow for another
48 h. Only doxycycline treated HeLa229 cells are used as control.
Total genomic DNA (10 mg) was digested either with MspI and
HhaI or with HindIII and separated by agarose gel electropho-
resis. Telomeric sequences were detected by Southern hybridiza-
tion using an end-labeled (CCCTAA)4 probe (Tel-C probe). The
position of molecular weight markers run is shown on the left. An
end-labeled probe against genomic GAPDH sequence (see table
S1) was used to check DNA quality and was visualized using
autoradiography. The gel was subsequently stripped and hybrid-
ized with an end-labeled probe against chlamydial DNA (Ctr
probe). Mock, Cells with no Chlamydia infection. (B) Schematic
diagram showing running pattern of different forms of DNA
in neutral-neutral 2D DNA electrophoresis. ssG DNA, single
stranded G-rich telomeric DNA. (C) Detection of circular
telomeric DNA in HeLa cells after Chlamydia infection. HeLa cells
were either mock infected or with Chlamydia trachomatis (Ctr) for
24 h. Subsequently, infected cells were cultured for 2 more days in
presence of 1 mg/ml of doxycycline. 8 mg of total genomic DNA
from each sample was processed for 2D DNA electrophoresis
and subsequent Southern hybridization using Tel-C probe. Black
arrowhead indicates circular telomeric DNA. Mock, without
Chlamydia infection. dpi, days post infection.
(TIF)
Figure S2 (A) HSB-2 cells infected with HHV-6A were studied
for infectious viral particle formation by transmission electron
microscopy. Numerous infectious viral particles are observed
in most of the cells. (B) FISH analysis was used to study
chromosomal integration of HHV-6A in the same HSB-2 cells.
A custom designed Alexa488-tagged PNA oligonucleotide probe
against HHV-6 DNA was used to detect integrated HHV-6 DNA.
Co-hybridization with Cy5-tagged Tel-C probe was used to study
telomeric co-localization. HHV-6A integrated chromosome is
highlighted. (C) 8 mg of total genomic DNA from HSB-2 cells
infected with HHV-6A and 16 mg of total genomic DNA from
HSB-ML cells infected with C. trachomatis (Ctr) were digested with
MspI and HhaI and were processed for 2D-DNA electrophoresis
and subsequent Southern hybridization with telomere specific
probes. (D) 8 mg of total genomic DNA from HSB-2 cells without
having HHV-6A infection and HSB-ML cells without Chlamydia
infection (control) were digested with MspI and HhaI and were
processed as mentioned above. (E) Samples described under (B)
were digested with S1 nuclease and similarly processed as
described above.
(TIF)
Figure S3 Detection of short t-circles originating from HHV-6
DRL by Southern hybridization. (A) Total genomic DNA from
HSB-2 cells having ciHHV-6 as well as productive HHV-6
infection was digested with either BamHI or HindIII and run on
a 1% agarose gel and processed for Southern hybridization.
The membrane was probed first with HHV-6 probe 2, stripped
and re-probed with HHV-6 probe 1. Finally the membrane was
probed with telomeric-C probe. Desired bands, which are
detected by both the probes, are marked with blue arrow.
HSB-2 total DNA without having viral infection served as a
negative control. Bands detected by both the HHV-6 probes are
indicated with blue arrowhead. (B, C) Diagrammatic represen-
tation of possible band sizes after BamHI and HindIII digestion
of HSB-2 DNA having ciHHV-6 as well as productive HHV-6
infection. Approximate location of HindIII or BamHI digestion
sites within and around viral DR are marked with dotted lines.
The location of probes used to detect specific regions of viral
DNA and their expected sizes are indicated. Positions of
restriction digestion sites and expected band lengths are based
on HHV-6A (U1102) genome (X83413.1).
(TIF)
Figure S4 (A) KBM-7 cells infected with HHV-6A were studied
for infectious viral particle formation by transmission electron
microscopy. Numerous viral nuclear capsids (marked with white
arrowhead) were observed in most of the cells. (B) Diagram of the
principle of inverse PCR to detect short t-circles. The position of
the forward (For1) and reverse (Rev1) primers is indicated (see
table S1 for primer sequence information).
(TIF)
Figure S5 Sequence details of circular/concatemeric HHV-6
DNA having single incomplete DR. (A) Sequence details of
,3.2 kb band from Figure 5B showing reconstitution of
incomplete DR by fusion of DRL with a part of DRR. (B, C)
Sequence details of reconstituted incomplete DR formed by fusion
of DRR-T1 and DRL-T2. Full-length as well as short DR
sequences were PCR amplified using a pair of primer facing
against each other as described in Figure 5. Amplified sequences
are cloned and sequenced. Short DRs originating from telomeric
repeats confirm telomere mediated DR reconstitution.
(TIF)
Figure S6 Strong sequence variation in HHV-6 DR-T1 as
revealed by sequencing of circular/concatemeric HHV-6 DNA
having single incomplete DR. (A–C) Sequence details of
reconstituted incomplete DR formed by fusion of DRR-T1 and
DRL-T2. Variable length of telomeric repeats at the junction site
is marked with red font. Full-length as well as short DR
sequences are PCR amplified using a pair of primer facing
against each other as described in Figure 5. Amplified sequences
are cloned into TOPO 2.1 vector and sequenced. Short DRs
originating from telomeric repeats confirm telomere mediated
DR reconstitution.
(TIF)
Table S1 Oligos used for PCR and Southern hybridizations.
(PDF)
Text S1 Sequence information of inverse PCR showing junction
regions within short t-circles formed from viral DR. (A) Sequence
details of the junction region as derived from approximately 1.7 kb
short t-circle PCR products isolated from HSB-2 cell DNA with
HHV-6A infection (see Figure 4D). (B) Five different length short
t-circle PCR products (see Figure 4D), more than 2 kb in size and
isolated from HSB-ML cells, shows similar sequence homology
with variable size of telomeric repeats.
(PDF)
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